亨泰(00197.HK)就收購擬貨幣投資及交易平台訂立諒解備忘錄
格隆匯5月28日丨亨泰(00197.HK)發佈公吿,2021年5月28日,買方(為公司的全資附屬公司)與賣方就可能收購事項訂立無法律約束力的備忘錄。據此,賣方給予買方由備忘錄日期起計兩個月的備忘錄專屬期具有法律約束力。可能收購事項受限於買方信納其將予進行關於目標公司及其附屬公司的盡職審查,以及買方與賣方於可能收購事項的最終條款達成磋商,方可作實。
目標公司是一間於英屬處女羣島註冊成立的私人有限公司,主要從事提供虛擬貨幣投資及交易平台以及提供數位資產託管及數位財富管理。而賣方為一名香港商人和獨立第三方,目前擁有目標公司的大部分股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.